Larubis, Berlyn T.

HRN: 21 97 69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2022
CEFUROXIME 1.5GM (VIAL)
11/28/2022
12/05/2022
INTRAVENOUS
750 Mg
Q8h
Prophylaxis

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines